QI
CRHM

QS Investors’s CRH Medical Corporation CRHM Stock Holding History

QS Investors’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-157,300
Closed -$211K – 1730
2020
Q1 		$211K Buy
157,300
+96,000
+157% +$314K ﹤0.01% 1050
2019
Q4 		$213K Buy
61,300
+14,000
+30% +$44.2K ﹤0.01% 1172
2019
Q3 		$146K Sell
47,300
-12,700
-21% -$37.7K ﹤0.01% 1282
2019
Q2 		$182K Hold
60,000
– – ﹤0.01% 1242
2019
Q1 		$160K Buy
+60,000
New +$185K ﹤0.01% 1281

Other funds holding CRHM

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QS Investors's CRHM Position: Q2 2020 in Review

QS Investors sold out of CRH Medical Corporation (CRHM) in Q2 2020, closing a stake of 157,300 shares — an estimated $211K sold.

QS Investors first reported a position in CRHM in Q1 2019 and held it in 5 quarters. The position peaked at $213K in Q4 2019. 44 funds tracked by Wall St. Rank hold CRHM as of Q2 2020.

  • QS Investors reported no remaining CRH Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • QS Investors sold 157,300 CRH Medical Corporation shares in Q2 2020, an estimated $211K.
  • QS Investors first reported a position in CRH Medical Corporation in Q1 2019 and held it in 5 quarters.
  • QS Investors's CRH Medical Corporation position peaked at $213K in Q4 2019.
  • 44 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2020.

Based on QS Investors's 13F filing for Q2 2020, filed 14 Aug 2020.